Article
Characterization of an inhibitor-resistant enzyme IRT-2 derived from TEM-2 beta-lactamase produced by Proteus mirabilis strains.
The Journal of antimicrobial chemotherapy - 1 Aug 1996
Bret L, Chanal C, Sirot D, Labia R, Sirot J
Abstract excerpt
Ten clinical isolates of Proteus mirabilis were found to produce an inhibitor-resistant TEM beta-lactamase (IRT) in association with a TEM-1 enzyme. The IRT enzyme was derived from TEM-2. The blaIRT gene differs from blaTEM-2 gene by one point mutation which leads to the amino-acid substitution Arg-->Ser at position 244, as observed for the original IRT-2 enzyme derived from TEM-1 reported in Escherichia coli....
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
